Comparison Overview
Accellacare
Accellacare
N/A
Last Update: 14/12/2025
Accellacare delivers clinical trial services to pharmaceutical, biotechnology, medical device industries. Accellacare extends across the globe with 112 active research sites in eight countries with expertise in a wide range of therapeutic areas. It has relationships wi...
Takeda
Tokyo, JP
Last Update: 20/05/2026
We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things...
Compliance Ranges Comparison
Accellacare
Takeda
Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Accellacare in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Takeda in 2026.
Incident History - Accellacare (X = Date, Y = Severity)
Accellacare cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Takeda (X = Date, Y = Severity)
Takeda cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
Accellacare
Takeda
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.